Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Massachusetts for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Massachusetts only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Massachusetts (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Kameran Lashkari (NPI 1710973425)

Field	Value
Entity Type	Individual
Organization	Kameran Lashkari
Address	500 Faunce Corner Rd Ste 110
City	North Dartmouth
State	MA
ZIP	02747
Taxonomy	Ophthalmology Physician
NPI Enumerated	September 27, 2005

Payer Source	Total Paid
Medicare	$2M
Medicaid	$0

Key Findings

This provider is an ophthalmology specialist with a clear retina/intravitreal injection service-line focus: J0178 (aflibercept) alone accounts for $1.5M revenue and 75.1% of the provider's Medicare revenue, and the portfolio also includes J2778 (ranibizumab) and J9035 (bevacizumab). High counts for injection codes (e.g., 2.2K claims for J0178) plus retinal imaging codes indicate a practice organized around recurrent, drug-delivery procedures and retinal disease management rather than predominantly primary eye care.

Revenue concentration is extreme at the code level: the precomputed top 3 Medicare codes by revenue account for 88.7% of this provider's total Medicare revenue, so the financial profile is heavily dependent on the aflibercept/anti-VEGF treatment line. That concentration creates operational sensitivity to shifts in utilization, reimbursement, or supply related to those specific drugs.

Payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $2M while there is no Medicaid billing on file, so the provider has little to no Medicaid exposure and relies almost entirely on Medicare volume for reported public-payer revenue. This makes analyses of Medicare trends highly material for forecasting the provider's public-revenue trajectory.

Competitive standing for the revenue-driving pharmaceutical code is solid but not dominant nationally: J0178 ranks #423 of 3204 providers nationally (87th percentile; described as typical, unremarkable volume for this code), indicating above-average but not rare national scale for aflibercept injections. The second and third largest codes, 67028 and J2778, also sit in the middle-to-upper range of national distributions (67028 at the 84th percentile; J2778 at the 54th percentile), which together portray a consistently active retina practice but not a market-leading outlier on injections alone.

Retinal imaging services are a notable outlier relative to peers: 92134 shows 2.3K claims, $32 avg paid/claim, and $72.8K revenue (3.6% of Medicare revenue) and is characterized as an extreme outlier (97th percentile, far above typical national volume). This suggests the provider performs unusually high volumes of computerized retinal diagnostic imaging, reinforcing the interpretation of a retina-focused practice with substantial diagnostic throughput alongside injections.

Other code-level signals add nuance to scope of care: the practice reports both comprehensive/evaluation codes (92014 and 92012) with typical, unremarkable volumes, while certain procedures such as J7312 and 67210 appear at much lower percentiles (J7312 at the 12th percentile; 67210 at the 4th percentile). In combination, this mix signals a clinical emphasis on intravitreal pharmacotherapy and retinal imaging rather than on higher-volume surgical retinal laser procedures.

Tenure on file is long: the NPI was enumerated on 2005-09-27 (~21 years ago), indicating a well-established presence in the market that may correspond with steady referral patterns and accumulated follow-up patient volume necessary for repeated intravitreal treatment workflows. That longevity supports plausibility of the high imaging and injection volumes observed.

From a payer-contracting and risk perspective, the absence of Medicaid billing and the concentration into a few high-revenue drug codes imply concentrated revenue risk and limited Medicaid leverage; payers and partners evaluating this provider should treat Medicare trends in anti-VEGF prescribing and retinal imaging utilization as primary drivers of revenue performance.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

13 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,230	$690	$1.5M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,610	$90	$151.4K
J2778	Injection, ranibizumab, 0.1 mg	720	$170	$124.7K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,270	$30	$72.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	560	$90	$52.2K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	590	$70	$39.9K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	150	$160	$22.9K
J9035	Injection, bevacizumab, 10 mg	330	$50	$17.2K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	70	$110	$7.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	70	$90	$6.5K

Showing 1–10 of 13

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Massachusetts Distribution

Kameran Lashkari — 1 of 13 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Massachusetts

Full comparison — all codes billed, vs. state median

13 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	12	90	790	$690	$826.5K
J2778	11	30	560	$180	$200.7K
67028	20	120	570	$100	$80.7K
J7312	4	10	220	$160	$35.7K
92014	208	1,070	160	$90	$30.1K
J9035	31	80	250	$50	$19.7K
99214	9,664	15,410	110	$80	$15.6K
92012	40	560	90	$70	$12.4K
92134	26	670	70	$30	$10.6K
67210	4	10	20	$390	$7.3K

Showing 1–10 of 13

Related Providers

Other providers that share a Tax Identification Number (TIN) with Kameran Lashkari, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Advanced Eye Centers Inc	MA	Optometrist	$0	$6.4M
Bryan Hong	MA	Retina Specialist (Ophthalmology) Physician	$2.5M	$0
Brad Baker	MA	Retina Specialist (Ophthalmology) Physician	$2.5M	$0
Marianeli Rodriguez	MA	Ophthalmology Physician	$2.4M	$0
Namrata Nandakumar	MA	Ophthalmology Physician	$2.2M	$0
Mehdi Najafi	MA	Ophthalmology Physician	$1.8M	$0
Frank Mccabe	MA	Retina Specialist (Ophthalmology) Physician	$1.5M	$0
Candescent Eye Health Surgicenter, LLC	MA	Ambulatory Surgical Clinic/Center	$1.1M	$369.1K
Milford-franklin Eye Center, LLC	MA	Ambulatory Surgical Clinic/Center	$1.2M	$71.9K
Nora Muakkassa	CO	Ophthalmology Physician	$1.3M	$0

Nearby Providers

Other providers in the same ZIP code as Kameran Lashkari, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Steward Medical Group, Inc	MA	Internal Medicine Physician	$0	$34.5M
Southcoast Emergency Medical Services Inc	MA	Land Ambulance	$2M	$9.1M
Pacheco Aba Service And Behavioral Consulting PLLC	MA	Behavior Analyst	$0	$9.3M
Fall River-new Bedford Regional Mri, Limited Partnership	MA	Magnetic Resonance Imaging (MRI) Clinic/Center	$637.1K	$3.2M
Precision Toxicology, LLC	MA	Clinical Medical Laboratory	$222.3K	$3.2M
Stat Ambulance Service Inc	MA	Ambulance	$779.6K	$2.2M
Coastal Sleep Diagnostics, LLC	MA	Sleep Disorder Diagnostic Clinic/Center	$143.6K	$1.4M
Corey Westerfeld	MA	Ophthalmology Physician	$1.2M	$0
Advanced Eye Surgery Center	MA	Ambulatory Surgical Clinic/Center	$926.1K	$136.2K
Amanda Raposo	MA	Psychiatric/Mental Health Nurse Practitioner	$109.9K	$792.8K

Kameran Lashkari — Billing Profile & Reimbursement Data

Sign up for Kameran Lashkari — Billing Profile & Reimbursement Data policy alerts

Kameran Lashkari — Billing Profile & Reimbursement Data

Sign up for Kameran Lashkari — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References